Results 181 to 190 of about 30,205 (229)
Some of the next articles are maybe not open access.
Thromboprophylaxis in Pregnancy
Obstetrics and Gynecology Clinics of North America, 2018Venous thromboembolism is a leading cause of maternal morbidity and mortality worldwide. Identifying women who are at greatest risk for venous thromboembolism, and managing their pregnancies with appropriate thromboprophylaxis is essential to decreasing this life-threatening condition. Those at greatest risk are patients with thrombophilias, a personal
Diana, Kolettis, Sabrina, Craigo
openaire +2 more sources
Thromboprophylaxis in multiple myeloma
Leukemia & Lymphoma, 2022Venous thromboembolism (VTE) in multiple myeloma (MM) can be secondary to patient-, disease-, and/or treatment-related factors. The development of VTE may result in significant morbidity with the highest risk during the first year after diagnosis. This clinical review provides an evidence-based summary to guide practicing oncologists in the use of ...
Nishanth, Thalambedu, Samer, Al Hadidi
openaire +2 more sources
British journal of hospital medicine, 1993
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
R, Grace, B J, Hunt
openaire +1 more source
Thromboprophylaxis in Stroke Patients
Stroke, 2005To the Editor: The risk for venous thromboembolism (VTE) in medical patients, including those with stroke, is similar to that in moderate-risk surgery patients.1 In contrast to surgical patients, prevention of VTE has been less characterized in hospitalized medical patients because trials are generally limited in number and smaller in size.
LIPPI, Giuseppe, GUIDI, Giancesare
openaire +3 more sources
Thromboprophylaxis in neurosurgical patients
Seminars in Hematology, 2000Neurosurgical patients constitute one of the highest risk groups for postoperative thromboembolic complications. Physical methods of thromboprophylaxis have been successful in reducing the incidence of postoperative deep vein thrombosis (DVT) but the residual incidence remains considerable.
openaire +3 more sources
Thromboprophylaxis in Spinal Surgery
Spine, 2018Study Design. Systematic review and meta-analysis. Objective. Determine the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in spinal surgery patients receiving no thromboprophylaxis, mechanoprophylaxis, and chemoprophylaxis ...
William P, Mosenthal +6 more
openaire +2 more sources
Emerging concepts in thromboprophylaxis
Pathophysiology of Haemostasis and Thrombosis, 2002Venous thromboembolism (VTE), comprising pulmonary embolism (PE) and deep vein thrombosis (DVT), is a common and potentially fatal disease. Since it is frequently asymptomatic, prevention is the most effective means to reduce morbidity and mortality. Although thromboprophylaxis is recommended in patients undergoing general and orthopaedic surgery and ...
openaire +2 more sources
Thromboprophylaxis in Emergency Surgery
Pathophysiology of Haemostasis and Thrombosis, 1993Except for hip fracture surgery, emergency surgery has been only exceptionally studied concerning thromboprophylaxis. There are, however, several reasons to believe the frequency to be fairly high and that the patient group would be in need of prophylaxis.
D, Bergqvist +7 more
openaire +2 more sources
Thromboprophylaxis in cancer outpatients
Blood, 2008In this issue of Blood, Khorana and colleagues report a simple and practical model for the prediction of symptomatic venous thrombosis after the initiation of chemotherapy in cancer outpatients.
openaire +2 more sources
Thromboprophylaxis in Cancer Patients
Seminars in Thrombosis and Hemostasis, 2014Cancer-associated thrombosis (CAT) is frequent and associated with significant morbidity and mortality among cancer patients. Hospitalized medically ill cancer patients are considered to be at high risk of CAT complications. Parenteral thromboprophylaxis with low-molecular-weight heparin is likely to reduce the risk of venous thromboembolism in this ...
Marc, Carrier, Agnes Y Y, Lee
openaire +2 more sources